Carnitine and Viracept drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Carnitine (l - carnitine) and Viracept (nelfinavir mesylate). Common drug interactions include hypophosphataemia among males.

The phase IV clinical study analyzes what interactions people have when they take Carnitine and Viracept. It is created by eHealthMe based on reports of 21 people who take the same drugs from the FDA, and is updated regularly.

What is Carnitine?

Carnitine has active ingredients of l - carnitine. eHealthMe is studying from 1,808 Carnitine users. Check the latest studies of Carnitine.

What is Viracept?

Viracept has active ingredients of nelfinavir mesylate. It is often used in hiv infection. eHealthMe is studying from 6,399 Viracept users. Check the latest studies of Viracept.



On Jul, 15, 2026

21 people who take Carnitine and Viracept together, and have interactions are studied.

Carnitine and Viracept drug interactions.

What are the common drug interactions of Carnitine and Viracept, by gender? *:

female:

n/a

male:

  1. Hypophosphataemia (electrolyte disturbance in which there is an abnormally low level of phosphate in the blood)
  2. Sinus bradycardia (an unusually slow heartbeat due to heart disease)
  3. Dyspnoea (difficult or laboured respiration)
  4. Face oedema (swelling of face)
  5. Fatigue (feeling of tiredness)
  6. Lung infiltration (a substance that normally includes fluid, inflammatory exudates or cells that fill a region of lung)
  7. Pyrexia (fever)
  8. Rash maculo-papular (red area on the skin that is covered with small confluent bumps)
  9. Rash pruritic (redness with itching)
  10. Sore throat (pain or irritation of the throat)

What are the common drug interactions of Carnitine and Viracept, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Arrhythmia (irregular heartbeat)

30-39:

  1. Blood creatinine increased
  2. Carnitine decreased
  3. De toni-fanconi syndrome (disease of the proximal renal tubules[1] of the kidney in which glucose, amino acids, uric acid, phosphate and bicarbonate are passed into the urine)
  4. Hypophosphataemia (electrolyte disturbance in which there is an abnormally low level of phosphate in the blood)
  5. Proteinuria present

40-49:

  1. Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
  2. Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it)
  3. Dermatitis exfoliative (widespread scaling of the skin, often with itching (pruritus), skin redness (erythroderma), and hair loss)
  4. Dyspnoea (difficult or laboured respiration)
  5. Face oedema (swelling of face)
  6. Fatigue (feeling of tiredness)
  7. Lung infiltration (a substance that normally includes fluid, inflammatory exudates or cells that fill a region of lung)
  8. Pyrexia (fever)
  9. Rash maculo-papular (red area on the skin that is covered with small confluent bumps)
  10. Rash pruritic (redness with itching)

50-59:

  1. Blood pressure increased
  2. Bradycardia (abnormally slow heart action)
  3. Cardiac arrest
  4. Gout (uric acid crystals building up in the body)
  5. Hypertension (high blood pressure)
  6. Renal impairment (severely reduced kidney function)
  7. Syncope (loss of consciousness with an inability to maintain postural tone)
  8. Aortic atherosclerosis (degenerative process of aortic arteries)
  9. Atherosclerosis (disorder of the arteries)
  10. Cardiac disorder

60+:

  1. Pancreatitis acute (sudden inflammation of pancreas)
  2. Blood amylase increased

* Approximation only. Some reports may have incomplete information.

Do you take Carnitine and Viracept?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Carnitine and Viracept:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Carnitine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Viracept:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Carnitine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Viracept and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on l - carnitine and nelfinavir mesylate (the active ingredients of Carnitine and Viracept, respectively), and Carnitine and Viracept (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: